Awards & Recognitions: September 2024 September 27, 2024 Honors received by HMS faculty, postdocs, staff, and students
Gordon Freeman and Arlene Sharpe Receive Hamburg Award September 26, 2024 National Academy of Medicine award recognizes contributions to cancer immunotherapy
Researchers Harness AI to Repurpose Existing Drugs for Treatment of Rare Diseases September 25, 2024 New AI model identifies drug candidates from existing medicines for thousands of rare diseases
Study of Former NFL Players Finds 1 in 3 Believes They Have CTE September 24, 2024 Players also report higher rates of suicidality, treatable conditions that mimic CTE
Harvard Medical School Researcher Wins 2024 Lasker Award for Work That Led to GLP-1 Therapies September 19, 2024 Joel Habener, fellow scientists honored for discoveries paving the way to GLP-1 based treatments
Overriding Tumors’ Genetic Changes to Fight Cancer September 19, 2024 Study illuminates immune-evading mechanism, suggests how to turn the tables
Studies Deepen Understanding of LGBTQ Health Disparities September 13, 2024 Researchers point to solutions and opportunities for better health
Joan Reede Receives Lifetime Achievement Award September 13, 2024 Dean for Diversity and Community Partnership recognized for championing health equity
A New Artificial Intelligence Tool for Cancer September 4, 2024 ChatGPT-like AI model can diagnose, guide treatment, predict survival for multiple cancer types
When Community Is As Important As the Science August 30, 2024 PhD student Olúmídé Fagboyegun on the development of scientists and brain cells
Deadly Eastern Equine Encephalitis Virus Is a Familiar but Formidable Foe August 29, 2024 Harvard Medical School expert discusses challenges of diagnosis, treatment, and what lies ahead
What Enables Herpes Simplex Virus To Become Impervious to Drugs? August 27, 2024 Findings about how cold sore virus evades treatment offer broader clues on drug resistance